Head-to-head · Value Score
CoreAge Rx vs Citizen Meds
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Citizen Meds a 73. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameCitizen Meds
#169 · Grade C+ · Watch List
Est. first month
$125/mo intro (compounded); list price $299/mo
Save ~91% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 73 — an est. $99/mo first month, with no teaser step-up baked in. Citizen Meds isn't out of it: Someone comparing entry prices who will ask what happens when the markdown ends.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Citizen Meds |
|---|---|---|
| Value Score | 93 (A+) | 73 (C+) |
| Est. first month | $99/mo | $125/mo intro (compounded); list price $299/mo |
| Save vs brand-name | ~89% | ~91% |
| Semaglutide | $99/mo | $125/mo intro (compounded); list price $299/mo |
| Tirzepatide | $149/mo | $145/mo intro (compounded); list price $399/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Citizen Meds
Citizen Meds is a direct-to-consumer compounded GLP-1 seller advertising semaglutide at $125 and tirzepatide at $145, both marked down from list prices more than twice as high.
Why it's a deal
- Both molecules are priced openly on the storefront rather than held back until after an intake
- The entry rates are among the lower ones tracked here, at $125 for semaglutide and $145 for tirzepatide
- Ships discreetly, with the prescription and delivery handled in one flow
The fine print
- Every price is a markdown against a list price more than twice as high, and nothing on the site says how long the lower figure lasts
- No LegitScript or PCAB accreditation is displayed
- The states served are not disclosed anywhere on the site
- The About page advertised in the navigation does not load, so there is no company background to read
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Citizen Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.